Valuation RaySearch Laboratories AB OTC Markets
Stocks
RSLBF
SE0000135485
Advanced Medical Equipment & Technology
|
Delayed
OTC Markets
18:39:13 20/07/2026 +03
|
5-day change | 1st Jan Change | ||
| 18.85 USD | +11.87% |
|
-.--% | -20.80% |
| 08-25 | Aggregated short positions on the Stockholm Stock Exchange as of August 25 | FW |
| 08-19 | RaySearch executive sells shares for about $0.1m | FW |
Company Valuation: RaySearch Laboratories AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,937 | 2,331 | 3,096 | 7,405 | 7,816 | 6,068 | - | - |
| Change | - | 20.35% | 32.79% | 139.2% | 5.56% | -22.37% | - | - |
| Enterprise Value (EV) 1 | 2,397 | 2,727 | 3,281 | 7,414 | 7,804 | 6,223 | 6,075 | 5,870 |
| Change | - | 13.78% | 20.33% | 125.95% | 5.26% | -20.26% | -2.38% | -3.37% |
| P/E | -40.9x | 98.6x | 37.9x | 36.4x | 34.3x | 22.6x | 18.1x | 15.4x |
| PBR | 2.98x | 3.55x | 4.21x | 8.45x | 7.93x | 6.89x | 5.69x | 4.66x |
| PEG | - | -1x | 0x | 0x | 2.9x | 1.1x | 0.7x | 0.9x |
| Capitalization / Revenue | 3.02x | 2.76x | 3.03x | 6.21x | 5.81x | 4.35x | 3.72x | 3.28x |
| EV / Revenue | 3.74x | 3.23x | 3.21x | 6.22x | 5.81x | 4.46x | 3.72x | 3.18x |
| EV / EBITDA | 12.2x | 8.03x | 8.2x | 13.3x | 13.4x | 9.73x | 8.16x | 6.79x |
| EV / EBIT | -44.8x | 63.9x | 28.6x | 28.5x | 26.7x | 17.6x | 14x | 10.8x |
| EV / FCF | 234x | - | - | - | 21.7x | 32.9x | 21.2x | 16.1x |
| FCF Yield | 0.43% | - | - | - | 4.6% | 3.04% | 4.72% | 6.22% |
| Dividend per Share 2 | - | - | 0.7 | 3 | 3 | 4 | 4.77 | 5.87 |
| Rate of return | - | - | 0.78% | 1.39% | 1.32% | 2.22% | 2.64% | 3.25% |
| EPS 2 | -1.38 | 0.69 | 2.38 | 5.94 | 6.65 | 7.995 | 9.97 | 11.74 |
| Distribution rate | - | - | 29.4% | 50.5% | 45.1% | 50% | 47.8% | 50% |
| Net sales 1 | 641.1 | 843.6 | 1,022 | 1,192 | 1,344 | 1,396 | 1,632 | 1,848 |
| EBITDA 1 | 196.7 | 339.7 | 400.1 | 558 | 583.5 | 639.5 | 744.5 | 864.5 |
| EBIT 1 | -53.5 | 42.7 | 114.9 | 260.5 | 292.3 | 353 | 435 | 543.5 |
| Net income 1 | -47.3 | 23.8 | 81.57 | 203.5 | 227.8 | 272 | 337.5 | 422.5 |
| Net Debt 1 | 459.7 | 395.9 | 185.7 | 9.2 | -12.5 | 155 | 7 | -198 |
| Reference price 2 | 56.50 | 68.00 | 90.30 | 216.00 | 228.00 | 180.50 | 180.50 | 180.50 |
| Nbr of stocks (in thousands) | 34,283 | 34,283 | 34,283 | 34,283 | 34,283 | 33,618 | - | - |
| Announcement Date | 2/23/22 A | 2/28/23 A | 2/23/24 A | 2/21/25 A | 2/12/26 A | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 38x | 8.79x | 19.63x | -.--% | 39.78B | |
| 102.97x | 56.08x | 71.2x | 0.51% | 13.82B | |
| 80.63x | 12.54x | 51.72x | 0.73% | 5.55B | |
| -58.09x | 16.46x | -107.79x | - | 4.26B | |
| -6.92x | 61.8x | -7x | - | 2.07B | |
| 34.02x | - | - | -.--% | 1.53B | |
| -130.12x | - | - | - | 1.1B | |
| 7.02x | - | - | - | 1.03B | |
| Average | 8.44x | 31.13x | 5.55x | 0.31% | 8.64B | |
| Weighted average by Cap. | 43.92x | 21.27x | 24.11x | 0.18% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- RAY B Stock
- RSLBF Stock
- Valuation RaySearch Laboratories AB
Select your edition
All financial news and data tailored to specific country editions
